المؤلفون: Acurcio, FD, Guerra, AA, da Silva, MRR, Pereira, RG, Godman, B, Bennie, M, Nedjar, H, Rahme, E

المصدر: Current medical research and opinion. 36(4):677-686

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:142985190

المؤلفون: da Silva, WC, de Araujo, VE, Lima, EMEA, dos Santos, JBR, da Silva, MRR, Almeida, PHRF, Acurcio, FD, Godman, B, Kurdi, A, Cherchiglia, ML, Andrade, EIG

المصدر: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 32(6):585-606

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:139759353

المؤلفون: da Mata, AR, Alvares, J, Diniz, LM, da Silva, MRR, dos Santos, BRA, Guerra, AA, Cherchiglia, ML, Andrade, EIG, Godman, B, Acurcio, FD

المصدر: Expert review of clinical pharmacology. 9(5):739-746

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:133298673

المؤلفون: da Silva AM; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Horsth AL; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Timóteo ÉDS; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Faria RJ; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.; Graduate Program of Pharmaceutical Services, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Bazoni PS; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.; Graduate Program of Pharmaceutical Services, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Meira EF; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., Dos Santos JBR; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil., da Silva MRR; Health Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil. mike.ufes@gmail.com.; Graduate Program of Pharmaceutical Services, Federal University of Espírito Santo, Alegre, 29500-000, Brazil. mike.ufes@gmail.com.

المصدر: Scientific reports [Sci Rep] 2023 Oct 02; Vol. 13 (1), pp. 16558. Date of Electronic Publication: 2023 Oct 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Plants, Medicinal* , COVID-19*/epidemiology, Female ; Humans ; Brazil/epidemiology ; Cross-Sectional Studies ; Pandemics ; Surveys and Questionnaires ; Phytotherapy

المؤلفون: Bazoni PS; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre 29500-000, Brazil.; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Faria RJ; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre 29500-000, Brazil.; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Cordeiro FJR; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Timóteo ÉDS; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., da Silva AM; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Horsth AL; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Meira EF; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., Dos Santos JBR; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil., da Silva MRR; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre 29500-000, Brazil.; Health Technology Assessment and Economy Group, Federal University of Espírito Santo, Alegre 29500-000, Brazil.

المصدر: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Jun 16; Vol. 20 (12). Date of Electronic Publication: 2023 Jun 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Pandemics* , COVID-19*/epidemiology, Humans ; Female ; Brazil/epidemiology ; Cross-Sectional Studies ; Self Medication

المؤلفون: Dos Santos JBR; Health Technology Assessment and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alto Universitário S/N, Guararema, Alegre, Espírito Santo, 29500-000, Brazil., da Silva MRR; Health Technology Assessment and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alto Universitário S/N, Guararema, Alegre, Espírito Santo, 29500-000, Brazil. mruberson@gmail.com.

المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Nov; Vol. 78 (11), pp. 1749-1761. Date of Electronic Publication: 2022 Sep 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Sleep Initiation and Maintenance Disorders*/drug therapy, Antidepressive Agents/therapeutic use ; Benzodiazepines ; Double-Blind Method ; Humans ; Hypnotics and Sedatives/adverse effects ; Imidazoles ; Lipopolysaccharides ; Orexin Receptor Antagonists/adverse effects ; Orexins ; Pyrrolidines ; Receptors, GABA-A

المؤلفون: Dos Santos JBR; Department of Pharmacy and Nutrition, Health Economics and Technology Assessment Group; Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Brazil., Gomes RM; Department of Management and Incorporation of Technologies and Innovation in Health; Secretariat of Science, Technology and Strategic Inputs; Ministry of Health of Brazil, Brazil., da Silva MRR; Department of Pharmacy and Nutrition, Health Economics and Technology Assessment Group; Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Brazil.

المصدر: Expert review of clinical immunology [Expert Rev Clin Immunol] 2022 Sep; Vol. 18 (9), pp. 879-888. Date of Electronic Publication: 2022 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8409 (Electronic) Linking ISSN: 1744666X NLM ISO Abbreviation: Expert Rev Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Myasthenia Gravis*/drug therapy, Autoantibodies ; Humans ; Immunoglobulin G ; Infant, Newborn ; Receptors, Cholinergic/therapeutic use ; Technology

المؤلفون: Dos Santos JBR; Health Economics and Technology Assessment Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alto Universitário S/N, Guararema, Alegre, Espírito Santo, Brazil. Electronic address: jessica.barreto2203@gmail.com., da Silva MRR; Health Economics and Technology Assessment Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alto Universitário S/N, Guararema, Alegre, Espírito Santo, Brazil. Electronic address: michael.r.silva@ufes.br.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2022 May 05; Vol. 922, pp. 174902. Date of Electronic Publication: 2022 Mar 28.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Calcitonin Gene-Related Peptide Receptor Antagonists*/adverse effects , Migraine Disorders*/drug therapy , Migraine Disorders*/prevention & control, Adult ; Analgesics/therapeutic use ; Humans ; Piperidines ; Pyridines ; Pyrroles ; Quality of Life ; Spiro Compounds

المؤلفون: Faria RJ; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.; Health Assessment, Technology, and Economy Group, Federal University of Espírito Santo, Alegre, Brazil., Cordeiro FJR; Health Assessment, Technology, and Economy Group, Federal University of Espírito Santo, Alegre, Brazil., Dos Santos JBR; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.; Health Assessment, Technology, and Economy Group, Federal University of Espírito Santo, Alegre, Brazil., Alvares-Teodoro J; Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., Guerra Júnior AA; Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., Acurcio FA; Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., da Silva MRR; Pharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.; Health Assessment, Technology, and Economy Group, Federal University of Espírito Santo, Alegre, Brazil.

المصدر: Frontiers in pharmacology [Front Pharmacol] 2022 Apr 26; Vol. 13, pp. 878972. Date of Electronic Publication: 2022 Apr 26 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

المؤلفون: da Silva MRR; Health Assessment, Technology, and Economy Group; Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil.; College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Dos Santos JBR; Health Assessment, Technology, and Economy Group; Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil.; College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Almeida AM; College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Faculty of Medical Sciences of Minas Gerais, Medical Sciences Research and Graduate Institute, Minas Gerais, Brasil., Alvares-Teodoro J; College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Acurcio FA; College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Department of Social and Preventive Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

المصدر: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Apr; Vol. 22 (3), pp. 473-479. Date of Electronic Publication: 2021 Feb 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents*/therapeutic use , Arthritis, Psoriatic*/drug therapy, Adalimumab/therapeutic use ; Antibodies, Monoclonal ; Brazil ; Cost-Benefit Analysis ; Etanercept/therapeutic use ; Humans ; Quality-Adjusted Life Years